Management believes these excluded items are not reflective of our underlying performance and uses these non-GAAP financial measures to: evaluate our ongoing operating performance and compare it against prior periods, make operating decisions, forecast future periods, evaluate potential acquisitions, compare our operating performance against peer companies and assess certain compensation programs. The exclusion of these items from our non-GAAP financial results should not be interpreted as implying that these items are non-recurring, infrequent or unusual. We believe this non-GAAP financial information provides additional insight into our ongoing performance and have therefore chosen to provide this information to investors to help them evaluate the results of our ongoing operations and enable more meaningful period-to-period comparisons. These non-GAAP measures are provided in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.
A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. We have not provided a reconciliation with respect to any forward-looking non-GAAP financial data presented because we do not have and cannot reliably estimate certain key inputs required to calculate the most comparable GAAP financial data, such as the future price per share of our common stock for purposes of calculating the value of our common stock warrant liability, future acquisition costs, the possibility and impact of any litigation costs, changes in our GAAP effective tax rate and impairment charges. We believe these unknown inputs are likely to have a significant impact on any estimate of the comparable GAAP financial data.
Investors are cautioned against placing undue reliance on non-GAAP financial measures and are urged to review and consider carefully the adjustments made by management to the most directly comparable GAAP financial measures. Non-GAAP financial measures may have limited value as analytical tools because they may exclude certain expenses that some investors consider important in evaluating our operating performance or ongoing business performance. Further, non-GAAP financial measures may have limited value for purposes of drawing comparisons between companies because different companies may calculate similarly titled non-GAAP financial measures in different ways because non-GAAP measures are not based on any comprehensive set of accounting rules or principles.
Additional information and management’s assessment regarding why certain items are excluded from our non-GAAP measures are summarized below:
Amortization Expense - is related to acquired intangible assets which are based upon valuation methodologies, and are generally amortized over the expected life of the intangible asset at the time of acquisition, which may result in amortization amounts that vary over time. This is a non-cash expense and is not considered by management in making operating decisions.
Share-Based and Non-cash Compensation Expense - includes share-based compensation expense for awards that are equity and liability classified on our balance sheet. Share-based compensation expense is partially outside of our control due to factors such as stock price volatility and interest rates, which may be unrelated to our operating performance during the period in which the expense is incurred. It is an expense based upon valuation methodologies and assumptions that vary over time, and the amount of the expense can vary significantly between companies. Share-based and non-cash compensation expense amounts are not considered by management in making operating decisions.
Impairment-Related Charges - includes amounts associated with the impairment of intangible assets and property and equipment primarily associated with our decision in the third fiscal quarter of 2019 to cease design and development of optical modules and subsystems for Data Center applications, close certain product development facilities and reduce certain development activities for one of our product lines. We believe these amounts are not correlated to future business operations and including such charges does not reflect our ongoing operations.
Restructuring Charges - includes amounts primarily associated with approved plans to reduce staffing and manufacturing, research and development and administrative footprints, including amounts associated with the 2019 restructuring plan. We believe these amounts are not correlated to future business operations and including such charges does not reflect our ongoing operations.
Warrant Liability Expenses/Gains - are associated with mark-to-market fair value adjustments which are largely based on the value of our common stock, which may vary from period to period due to factors such as stock price volatility. We believe these amounts are not correlated to future business operations and including such charges does not reflect our ongoing operations.
Non-cash Interest, Net - includes amounts associated with the amortization of certain fees associated with the establishment or amendment of our credit agreement and term loans that are being amortized over the life of the agreement. We believe these amounts are non-cash in nature and not correlated to future business operations and including such charges does not reflect our ongoing operations.
Litigation Costs - includes gains, losses and expenses related to the resolution of other-than-ordinary-course threatened and actually filed lawsuits, contractual disputes and legal matters. These amounts are not considered by management in making operating decisions. We believe these amounts do not necessarily reflect the performance of our ongoing operations for the period in which such charges are recognized and the amounts of such gains, losses and expenses can vary significantly between companies.
Acquisition, Integration and Restructuring Related Costs - includes items such as professional fees, contingent consideration adjustments, severance payments, and salary and facility-related costs incurred that are not expected to have a continuing contribution to operations. We believe the exclusion of these items is useful in providing management a basis to evaluate ongoing operating activities and strategic decision making.
Equity Investment and Sale of Business Losses and Other - primarily includes losses associated with a non-marketable equity investment we have in a private business, impairment of our cost method investment, as well as other gains and losses associated with historical acquisitions and divestitures. The investment losses are non-cash in nature. We believe these items are not correlated to future business operations and including such amounts does not reflect our ongoing operations.
Tax Effect of Non-GAAP Adjustments - includes adjustments to arrive at an estimate of our adjusted non-GAAP income tax rate associated with our adjusted non-GAAP income over a period of time. We determine our adjusted non-GAAP income tax rate by using applicable rates in taxing jurisdictions and assessing certain factors including our historical and forecast earnings by jurisdiction, discrete items, cash taxes paid in relation to our adjusted non-GAAP net income before income taxes and our ability to realize tax assets. We generally assess this adjusted non-GAAP income tax rate quarterly and have utilized 8% for our fiscal years 2019 and 2020. Our historical effective income tax rate under GAAP has varied significantly from our adjusted non-GAAP income tax rate due primarily to changes in fair values of the common stock warrant liability, which are excluded from our adjusted net income and are neither deductible nor taxable for tax purposes, losses or gains associated with our equity method investment in a private business, income taxed in foreign jurisdictions at generally lower tax rates, intangible impairments, research and development tax credits and merger expenses. We believe it is beneficial for management to review our adjusted non-GAAP income tax rate on a consistent basis over periods of time. Items such as those noted above may have a significant impact on our GAAP income tax expense and associated effective tax rate over time.
Adjusted EBITDA - is a calculation that adds depreciation expense to our adjusted income from operations. Management reviews and utilizes this measure for operational analysis purposes. We believe competitors and others in the financial industry also utilize this measure for analysis purposes.
Free Cash Flow - is a calculation that starts with cash flow from operating activities and reduces this amount by our capital expenditures in the applicable period. Management reviews and utilizes this measure for cash flow analysis purposes. We believe competitors and others in the financial industry also utilize this measure for analyzing a company’s cash flow.
Incremental Shares - is the number of potential shares of common stock issuable upon the exercise of stock options, restricted stock, restricted stock units and warrants that were not included in the calculation of our GAAP diluted shares. We believe competitors and others in the financial industry utilize this measure for analysis purposes.
MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited and in thousands, except per share data) |
|||||||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||||||
|
October 2, 2020 |
|
July 3, 2020 |
|
September 27, 2019 |
|
October 2, 2020 |
|
September 27, 2019 |
||||||||||
|
|
|
|
|
|||||||||||||||
Revenue |
$ |
147,249 |
|
|
$ |
137,267 |
|
|
$ |
112,248 |
|
|
$ |
530,037 |
|
|
$ |
499,708 |
|
Cost of revenue |
69,533 |
|
|
66,391 |
|
|
59,323 |
|
|
259,871 |
|
|
279,000 |
|
|||||
Gross profit |
77,716 |
|
|
70,876 |
|
|
52,925 |
|
|
270,166 |
|
|
220,708 |
|
|||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||||||||
Research and development |
35,397 |
|
|
34,948 |
|
|
34,875 |
|
|
141,333 |
|
|
163,469 |
|
|||||
Selling, general and administrative |
29,990 |
|
|
29,982 |
|
|
26,849 |
|
|
124,306 |
|
|
153,286 |
|
|||||
Impairment charges |
— |
|
|
— |
|
|
700 |
|
|
— |
|
|
264,786 |
|
|||||
Restructuring (benefit) charges |
(356) |
|
|
(554) |
|
|
2,496 |
|
|
1,139 |
|
|
19,543 |
|
|||||
Total operating expenses |
65,031 |
|
|
64,376 |
|
|
64,920 |
|
|
266,778 |
|
|
601,084 |
|
|||||
Income (loss) from operations |
12,685 |
|
|
6,500 |
|
|
(11,995) |
|
|
3,388 |
|
|
(380,376) |
|
|||||
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||||||||
Warrant liability gain (expense) |
2,003 |
|
|
(19,511) |
|
|
(5,023) |
|
|
(12,948) |
|
|
765 |
|
|||||
Interest expense, net |
(5,239) |
|
|
(5,849) |
|
|
(8,661) |
|
|
(27,380) |
|
|
(35,803) |
|
|||||
Other income (expense), net |
7,843 |
|
|
(4,372) |
|
|
(3,507) |
|
|
(4,622) |
|
|
(7,739) |
|
|||||
Total other income (expense) |
4,607 |
|
|
(29,732) |
|
|
(17,191) |
|
|
(44,950) |
|
|
(42,777) |
|
|||||
Income (loss) before income taxes |
17,292 |
|
|
(23,232) |
|
|
(29,186) |
|
|
(41,562) |
|
|
(423,153) |
|
|||||
Income tax (benefit) expense |
(200) |
|
|
1,750 |
|
|
(39,702) |
|
|
4,516 |
|
|
(39,355) |
|
|||||
Net income (loss) |
$ |
17,492 |
|
|
$ |
(24,982) |
|
|
$ |
10,516 |
|
|
$ |
(46,078) |
|
|
$ |
(383,798) |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
||||||||||
Income (loss) per share - Basic |
$ |
0.26 |
|
|
$ |
(0.37) |
|
|
$ |
0.16 |
|
|
$ |
(0.69) |
|
|
$ |
(5.84) |
|
Income (loss) per share - Diluted |
$ |
0.22 |
|
|
$ |
(0.37) |
|
|
$ |
0.16 |
|
|
$ |
(0.69) |
|
|
$ |
(5.84) |
|
Weighted average common shares |
|
|
|
|
|
|
|
|
|
||||||||||
Shares - Basic |
66,893 |
|
|
66,796 |
|
|
66,077 |
|
|
66,606 |
|
|
65,686 |
|
|||||
Shares - Diluted |
69,286 |
|
|
66,796 |
|
|
66,378 |
|
|
66,606 |
|
|
65,686 |
|
|||||
MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited and in thousands) |
||||||||
|
|
October 2, 2020 |
|
September 27, 2019 |
||||
|
|
|
||||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
129,441 |
|
|
$ |
75,519 |
|
Short term investments |
|
203,711 |
|
|
101,226 |
|
||
Accounts receivable, net |
|
45,884 |
|
|
69,790 |
|
||
Inventories |
|
91,584 |
|
|
107,880 |
|
||
Income tax receivable |
|
1,240 |
|
|
16,661 |
|
||
Prepaids and other current assets |
|
9,659 |
|
|
27,506 |
|
||
Total current assets |
|
481,519 |
|
|
398,582 |
|
||
Property and equipment, net |
|
118,866 |
|
|
132,647 |
|
||
Goodwill and intangible assets, net |
|
445,910 |
|
|
495,955 |
|
||
Deferred income taxes |
|
41,935 |
|
|
43,812 |
|
||
Other investments |
|
17,745 |
|
|
23,613 |
|
||
Other long-term assets |
|
40,453 |
|
|
10,965 |
|
||
TOTAL ASSETS |
|
$ |
1,146,428 |
|
|
$ |
1,105,574 |
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Current portion of finance lease obligations and other |
|
$ |
1,368 |
|
|
$ |
1,084 |
|
Current portion of long-term debt |
|
6,885 |
|
|
6,885 |
|
||
Accounts payable |
|
23,043 |
|
|
24,822 |
|
||
Accrued liabilities |
|
63,654 |
|
|
42,045 |
|
||
Total current liabilities |
|
94,950 |
|
|
74,836 |
|
||
Finance lease obligations and other, less current portion |
|
28,994 |
|
|
29,506 |
|
||
Long-term debt obligations, less current portion |
|
652,172 |
|
|
655,272 |
|
||
Common stock warrant liability |
|
25,312 |
|
|
12,364 |
|
||
Other long-term liabilities |
|
44,854 |
|
|
19,700 |
|
||
Total liabilities |
|
846,282 |
|
|
791,678 |
|
||
Stockholders’ equity |
|
300,146 |
|
|
313,896 |
|
||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
$ |
1,146,428 |
|
|
$ |
1,105,574 |
|
MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited and in thousands) |
||||||||
|
|
Twelve Months Ended |
||||||
|
|
October 2, 2020 |
|
September 27, 2019 |
||||
|
|
|
||||||
|
|
|
|
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
||||
Net loss |
|
$ |
(46,078) |
|
|
$ |
(383,798) |
|
Depreciation and amortization |
|
78,826 |
|
|
104,418 |
|
||
Share-based compensation |
|
35,674 |
|
|
23,792 |
|
||
Warrant liability expense (gain) |
|
12,948 |
|
|
(765) |
|
||
Deferred income taxes |
|
3,340 |
|
|
(41,297) |
|
||
Loss on and impairment of minority equity investments |
|
5,867 |
|
|
7,481 |
|
||
Impairment and restructuring related charges |
|
— |
|
|
273,572 |
|
||
Other adjustments to reconcile loss to net operating cash |
|
5,302 |
|
|
4,255 |
|
||
Accounts receivable |
|
23,906 |
|
|
27,585 |
|
||
Inventories |
|
16,296 |
|
|
14,964 |
|
||
Change in other operating assets and liabilities |
|
35,316 |
|
|
(9,507) |
|
||
Net cash provided by operating activities |
|
171,397 |
|
|
20,700 |
|
||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
||||
Purchases of property and equipment |
|
(17,573) |
|
|
(37,963) |
|
||
Purchases, sales and maturities of investments |
|
(101,044) |
|
|
(1,094) |
|
||
Proceeds from divested business |
|
11,003 |
|
|
— |
|
||
Proceeds from sale of assets |
|
419 |
|
|
5,541 |
|
||
Acquisition of businesses, net |
|
— |
|
|
(375) |
|
||
Net cash used in investing activities |
|
(107,195) |
|
|
(33,891) |
|
||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
||||
Payments of long-term debt |
|
(6,885) |
|
|
(6,885) |
|
||
Payments on finance leases and other |
|
(1,708) |
|
|
(1,421) |
|
||
Proceeds from stock option exercises and employee stock purchases |
|
4,585 |
|
|
7,193 |
|
||
Repurchase of common stock - tax withholdings on equity awards |
|
(6,708) |
|
|
(4,137) |
|
||
Other adjustments |
|
— |
|
|
(578) |
|
||
Net used in financing activities |
|
(10,716) |
|
|
(5,828) |
|
||
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS |
|
436 |
|
|
(138) |
|
||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
|
53,922 |
|
|
(19,157) |
|
||
CASH AND CASH EQUIVALENTS — Beginning of period |
|
75,519 |
|
|
94,676 |
|
||
CASH AND CASH EQUIVALENTS — End of period |
|
$ |
129,441 |
|
|
$ |
75,519 |
|
MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC. RECONCILIATIONS OF GAAP TO NON-GAAP RESULTS (unaudited and in thousands, except per share data) |
|||||||||||||||||||||||||
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
||||||||||||||||||||
|
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
|||||||||||||||
Gross profit - GAAP |
$ |
77,716 |
|
52.8 |
|
$ |
70,876 |
|
51.6 |
|
$ |
52,925 |
|
47.2 |
|
$ |
270,166 |
|
51.0 |
|
$ |
220,708 |
|
44.2 |
|
Amortization expense |
4,347 |
|
3.0 |
|
4,347 |
|
3.2 |
|
5,773 |
|
5.1 |
|
17,462 |
|
3.3 |
|
29,847 |
|
6.0 |
|
|||||
Share-based and non-cash compensation expense |
914 |
|
0.6 |
|
1,024 |
|
0.7 |
|
836 |
|
0.7 |
|
4,143 |
|
0.8 |
|
2,973 |
|
0.6 |
|
|||||
Impairment-related charges |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(991) |
|
(0.2) |
|
|||||
Acquisition, integration and restructuring related costs |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
547 |
|
0.1 |
|
|||||
Adjusted gross profit (Non-GAAP) |
$ |
82,977 |
|
56.4 |
|
$ |
76,247 |
|
55.5 |
|
$ |
59,534 |
|
53.0 |
|
$ |
291,771 |
|
55.0 |
|
$ |
253,084 |
|
50.6 |
|
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
||||||||||||||||||||
|
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
|||||||||||||||
Operating expenses - GAAP |
$ |
65,031 |
|
44.2 |
|
$ |
64,376 |
|
46.9 |
|
$ |
64,920 |
|
57.8 |
|
$ |
266,778 |
|
50.3 |
|
$ |
601,084 |
|
120.3 |
|
Amortization expense |
(8,071) |
|
(5.5) |
|
(8,071) |
|
(5.9) |
|
(6,757) |
|
(6.0) |
|
(32,868) |
|
(6.2) |
|
(44,872) |
|
(9.0) |
|
|||||
Share-based and non-cash compensation expense |
(8,560) |
|
(5.8) |
|
(9,908) |
|
(7.2) |
|
(3,551) |
|
(3.2) |
|
(37,016) |
|
(7.0) |
|
(22,742) |
|
(4.6) |
|
|||||
Impairment and restructuring benefit (charges) |
356 |
|
0.2 |
|
554 |
|
0.4 |
|
(3,196) |
|
(2.8) |
|
(1,139) |
|
(0.2) |
|
(284,329) |
|
(56.9) |
|
|||||
Litigation costs |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(167) |
|
— |
|
|||||
Acquisition, integration and restructuring related benefit (costs) |
104 |
|
0.1 |
|
(22) |
|
— |
|
(366) |
|
(0.3) |
|
38 |
|
— |
|
(6,799) |
|
(1.4) |
|
|||||
Adjusted operating expenses (Non-GAAP) |
$ |
48,860 |
|
33.2 |
|
$ |
46,929 |
|
34.2 |
|
$ |
51,050 |
|
45.5 |
|
$ |
195,793 |
|
36.9 |
|
$ |
242,175 |
|
48.5 |
|
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
||||||||||||||||||||
|
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
|||||||||||||||
Income (loss) from operations - GAAP |
$ |
12,685 |
|
8.6 |
|
$ |
6,500 |
|
4.7 |
|
$ |
(11,995) |
|
(10.7) |
|
$ |
3,388 |
|
0.6 |
|
$ |
(380,376) |
|
(76.1) |
|
Amortization expense |
12,418 |
|
8.4 |
|
12,417 |
|
9.0 |
|
12,530 |
|
11.2 |
|
50,330 |
|
9.5 |
|
74,719 |
|
15.0 |
|
|||||
Share-based and non-cash compensation expense |
9,474 |
|
6.4 |
|
10,933 |
|
8.0 |
|
4,387 |
|
3.9 |
|
41,159 |
|
7.8 |
|
25,684 |
|
5.1 |
|
|||||
Impairment and restructuring (benefit) charges |
(356) |
|
(0.2) |
|
(554) |
|
(0.4) |
|
3,196 |
|
2.8 |
|
1,139 |
|
0.2 |
|
283,338 |
|
56.7 |
|
|||||
Litigation costs |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
167 |
|
— |
|
|||||
Acquisition, integration and restructuring related (benefit) costs |
(104) |
|
(0.1) |
|
22 |
|
— |
|
366 |
|
0.3 |
|
(38) |
|
— |
|
7,377 |
|
1.5 |
|
|||||
Adjusted income (loss) from operations (Non-GAAP) |
$ |
34,117 |
|
23.2 |
|
$ |
29,318 |
|
21.4 |
|
$ |
8,484 |
|
7.6 |
|
$ |
95,978 |
|
18.1 |
|
$ |
10,909 |
|
2.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Depreciation expense |
6,657 |
|
4.5 |
|
7,092 |
|
5.2 |
|
7,276 |
|
6.5 |
|
28,496 |
|
5.4 |
|
29,699 |
|
5.9 |
|
|||||
Adjusted EBITDA (Non-GAAP) |
$ |
40,774 |
|
27.7 |
|
$ |
36,410 |
|
26.5 |
|
$ |
15,760 |
|
14.0 |
|
$ |
124,474 |
|
23.5 |
|
$ |
40,608 |
|
8.1 |
|
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
||||||||||||||||||||
|
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
|||||||||||||||
Net income (loss) - GAAP |
$ |
17,492 |
|
11.9 |
|
$ |
(24,982) |
|
(18.2) |
|
$ |
10,516 |
|
9.4 |
|
$ |
(46,078) |
|
(8.7) |
|
$ |
(383,798) |
|
(76.8) |
|
Amortization expense |
12,418 |
|
8.4 |
|
12,418 |
|
9.0 |
|
12,530 |
|
11.2 |
|
50,330 |
|
9.5 |
|
74,719 |
|
15.0 |
|
|||||
Share-based and non-cash compensation expense |
9,474 |
|
6.4 |
|
10,933 |
|
8.0 |
|
4,387 |
|
3.9 |
|
41,159 |
|
7.8 |
|
25,715 |
|
5.1 |
|
|||||
Impairment and restructuring (benefit) charges |
(356) |
|
(0.2) |
|
(554) |
|
(0.4) |
|
3,196 |
|
2.8 |
|
1,139 |
|
0.2 |
|
283,338 |
|
56.7 |
|
|||||
Warrant liability (gain) expense |
(2,003) |
|
(1.4) |
|
19,511 |
|
14.2 |
|
5,023 |
|
4.5 |
|
12,948 |
|
2.4 |
|
(765) |
|
(0.2) |
|
|||||
Non-cash interest, net |
1,015 |
|
0.7 |
|
1,015 |
|
0.7 |
|
1,015 |
|
0.9 |
|
4,061 |
|
0.8 |
|
4,061 |
|
0.8 |
|
|||||
Litigation costs |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
167 |
|
— |
|
|||||
Acquisition, integration and restructuring related (benefit) costs |
(104) |
|
(0.1) |
|
22 |
|
— |
|
366 |
|
0.3 |
|
(38) |
|
— |
|
7,346 |
|
1.5 |
|
|||||
Equity investment, sale of business losses and other |
(7,770) |
|
(5.3) |
|
4,571 |
|
3.3 |
|
3,545 |
|
3.2 |
|
4,905 |
|
0.9 |
|
7,700 |
|
1.5 |
|
|||||
Tax effect of non-GAAP adjustments |
(2,596) |
|
(1.8) |
|
(224) |
|
(0.2) |
|
(39,772) |
|
(35.4) |
|
(1,319) |
|
(0.2) |
|
(37,686) |
|
(7.5) |
|
|||||
Adjusted net income (loss) (Non-GAAP) |
$ |
27,570 |
|
18.7 |
|
$ |
22,710 |
|
16.5 |
|
$ |
806 |
|
0.7 |
|
$ |
67,107 |
|
12.7 |
|
$ |
(19,203) |
|
(3.8) |
|
|
Three Months Ended |
Twelve Months Ended |
||||||||||||||||||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
|||||||||||||||||||||||||
|
Net Income (Loss) |
Income (loss) per diluted share |
Net Income (Loss) |
Income (loss) per diluted share |
Net Income (Loss) |
Income (loss) per diluted share |
Net Income (Loss) |
Income (loss) per diluted share |
Net Income (Loss) |
Income (loss) per diluted share |
||||||||||||||||||||
Net income (loss) - GAAP |
$ |
17,492 |
|
|
$ |
(24,982) |
|
|
$ |
10,516 |
|
|
$ |
(46,078) |
|
|
$ |
(383,798) |
|
|
||||||||||
Warrant liability gain |
(2,003) |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
|||||||||||||||
Net income (loss) - diluted |
$ |
15,489 |
|
$ |
0.22 |
|
$ |
(24,982) |
|
$ |
(0.37) |
|
$ |
10,516 |
|
$ |
0.16 |
|
$ |
(46,078) |
|
$ |
(0.69) |
|
$ |
(383,798) |
|
$ |
(5.84) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Adjusted net income (loss) (Non-GAAP) |
$ |
27,570 |
|
$ |
0.40 |
|
$ |
22,710 |
|
$ |
0.33 |
|
$ |
806 |
|
$ |
0.01 |
|
$ |
67,107 |
|
$ |
0.98 |
|
$ |
(19,203) |
|
$ |
(0.29) |
|
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
||||||||||
|
Shares |
|
Shares |
|
Shares |
|
Shares |
|
Shares |
|
|||||
Diluted shares - GAAP |
69,286 |
|
|
66,796 |
|
|
66,378 |
|
|
66,606 |
|
|
65,686 |
|
|
Incremental shares |
— |
|
|
1,767 |
|
|
358 |
|
|
1,756 |
|
|
387 |
|
|
Adjusted diluted shares (Non-GAAP) |
69,286 |
|
|
68,563 |
|
|
66,736 |
|
|
68,362 |
|
|
66,073 |
|
|
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
||||||||||||||||||||
|
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
|||||||||||||||
Interest expense, net - GAAP |
$ |
5,239 |
|
3.6 |
|
$ |
5,849 |
|
4.3 |
|
$ |
8,661 |
|
7.7 |
|
$ |
27,380 |
|
5.2 |
|
$ |
35,803 |
|
7.2 |
|
Non-cash interest expense |
(1,016) |
|
(0.7) |
|
(1,015) |
|
(0.7) |
|
(1,015) |
|
(0.9) |
|
(4,061) |
|
(0.8) |
|
(4,061) |
|
(0.8) |
|
|||||
Adjusted interest expense (Non-GAAP) |
$ |
4,223 |
|
2.9 |
|
$ |
4,834 |
|
3.5 |
|
$ |
7,646 |
|
6.8 |
|
$ |
23,319 |
|
4.4 |
|
$ |
31,742 |
|
6.4 |
|
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||||||||||||
|
October 2, 2020 |
July 3, 2020 |
September 27, 2019 |
October 2, 2020 |
September 27, 2019 |
||||||||||||||||||||
|
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
|||||||||||||||
Cash flow from (used in) operations |
$ |
74,403 |
|
50.5 |
|
$ |
34,056 |
|
24.8 |
|
$ |
(7,578) |
|
(6.8) |
|
$ |
171,397 |
|
32.3 |
|
$ |
20,700 |
|
4.1 |
|
Capital expenditures |
(4,915) |
|
(3.3) |
|
(3,622) |
|
(2.6) |
|
(6,058) |
|
(5.4) |
|
(17,573) |
|
(3.3) |
|
(37,963) |
|
(7.6) |
|
|||||
Free cash flow (Non-GAAP) |
$ |
69,488 |
|
47.2 |
|
$ |
30,434 |
|
22.2 |
|
$ |
(13,636) |
|
(12.1) |
|
$ |
153,824 |
|
29.0 |
|
$ |
(17,263) |
|
(3.5) |
|
Free cash flow as a percentage of Adjusted net income |
252 |
% |
|
134 |
% |
|
(1,692) |
% |
|
229 |
% |
|
(90) |
% |
|